4//SEC Filing
Jordan Julie 4
Accession 0000950170-23-038564
CIK 0001661998other
Filed
Aug 3, 8:00 PM ET
Accepted
Aug 4, 4:08 PM ET
Size
8.4 KB
Accession
0000950170-23-038564
Insider Transaction Report
Form 4
Jordan Julie
Chief Medical Officer
Transactions
- Exercise/Conversion
Common Stock
2023-08-02+350→ 2,869 total - Sale
Common Stock
2023-08-02$1.31/sh−99$130→ 2,770 total - Exercise/Conversion
Restricted Stock Units
2023-08-02−350→ 0 total→ Common Stock (350 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. The restricted stock units have no expiration date.
- [F2]The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 instruction entered into on September 14, 2021 solely with the intent to cover taxes in connection with the vesting of certain previously reported restricted stock units.
- [F3]The restricted stock units vested and settled in full on August 2, 2023.
Documents
Issuer
Homology Medicines, Inc.
CIK 0001661998
Entity typeother
Related Parties
1- filerCIK 0001968554
Filing Metadata
- Form type
- 4
- Filed
- Aug 3, 8:00 PM ET
- Accepted
- Aug 4, 4:08 PM ET
- Size
- 8.4 KB